Caricamento...
Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with statin and ezetimibe therapy, and those with homozygous FH (HoFH) usually require a...
Salvato in:
| Pubblicato in: | Endocrinol Metab (Seoul) |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Endocrine Society
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090480/ https://ncbi.nlm.nih.gov/pubmed/33866776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2021.964 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|